SIGA Technologies, Inc. (NASDAQ: SIGA) is a pharmaceutical company specializing in the development and commercialization of therapeutic solutions for some of the most lethal disease causing pathogens in the world - smallpox, Ebola, dengue, Lassa fever and other dangerous viruses. SIGA's business is to discover, develop, manufacture and successfully commercialize drugs to prevent and treat these high priority threats. The Company's mission is to disarm dreaded viral diseases and create robust, modern biodefense countermeasures.
